Skip to main content
. 2024 Feb 19;16(2):e54440. doi: 10.7759/cureus.54440

Table 1. Characteristics of the study groups.

BMI: body mass index, DBP: diastolic blood pressure, SBP: systolic blood pressure, SD: standard deviation

*All patients with hypertension were on antihypertensive therapy, **All patients with hyperlipidemia were on statin therapy

  DPP-4±metformin (n=25) Metformin only (n=25) p-value
Parameter Mean±SD Median (25th-75th percentiles)  n (%) Mean±SD Median (25th-75th percentiles)  n (%)  
Age (year) 51.56±9.26 53 (42-59)   51.20±7.68 49 (45.50-56.50)   p=0.922
Duration of diabetes (year) 4.5±3.54 4 (1-7)   2.4±2.32 1 (1-3)   p=0.108
Education (year) 5.48±1.66 5 (5-5)   6±2.40 5 (5-5)   p=0.253
Weight (kg) 85.46±15.44 85 (75.50-90)   84.94±11.44 86 (78.50-94.50)   p=0.895
BMI (kg/m2) 32.13±6.35 30.97 (28.14-35.68)   31.87±4.77 30.60 (28.73-34.56)   p=0.942
SBP (mmHg) 129.60±11.36 130 (120-140)   127.60±15.35 120 (120-140)   p=0.416
DBP (mmHg) 82±8.54 80 (80-90)   80.40±7.35 80 (75-90)   p=0.407
Gender (female/male)     17/8 (68%)     14 /11 (56%) p=0.382
Hypertension (yes/no)*     13/12 (52%)     8/17 (32%) p=0.152
Hyperlipidemia (yes/no)**     10/15 (40%)     6/19 (24%) p=0.225